MX6962E - Procedimiento para la preparacion de una composicion farmaceutica antidiarreica - Google Patents

Procedimiento para la preparacion de una composicion farmaceutica antidiarreica

Info

Publication number
MX6962E
MX6962E MX819461U MX946181U MX6962E MX 6962 E MX6962 E MX 6962E MX 819461 U MX819461 U MX 819461U MX 946181 U MX946181 U MX 946181U MX 6962 E MX6962 E MX 6962E
Authority
MX
Mexico
Prior art keywords
procedure
preparation
pharmaceutical composition
antidiarrheal
antidiarrheal pharmaceutical
Prior art date
Application number
MX819461U
Other languages
English (en)
Inventor
Terence James Ward
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of MX6962E publication Critical patent/MX6962E/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX819461U 1980-05-27 1981-05-22 Procedimiento para la preparacion de una composicion farmaceutica antidiarreica MX6962E (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8017377 1980-05-27
GB8104410 1981-02-12

Publications (1)

Publication Number Publication Date
MX6962E true MX6962E (es) 1987-01-08

Family

ID=26275656

Family Applications (1)

Application Number Title Priority Date Filing Date
MX819461U MX6962E (es) 1980-05-27 1981-05-22 Procedimiento para la preparacion de una composicion farmaceutica antidiarreica

Country Status (18)

Country Link
US (1) US4443467A (es)
EP (1) EP0040947B1 (es)
AU (1) AU539121B2 (es)
CA (1) CA1158558A (es)
DE (1) DE3175672D1 (es)
DK (1) DK228381A (es)
ES (3) ES8302647A1 (es)
FI (1) FI811601L (es)
GB (1) GB2080107B (es)
GR (1) GR74922B (es)
IL (1) IL62809A (es)
IT (1) IT1136619B (es)
MX (1) MX6962E (es)
MY (1) MY8700598A (es)
NZ (1) NZ197026A (es)
PH (2) PH16855A (es)
PT (1) PT73087B (es)
ZW (1) ZW11381A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714707A (en) * 1984-01-13 1987-12-22 Rorer Pharmaceutical Corporation Aryl substituted heterocycles for treating gastrointestinal motility dysfunction
GB8525013D0 (en) * 1985-10-10 1985-11-13 Wyeth John & Brother Ltd Antidiarrhoel agents
DK153442C (da) * 1985-10-14 1988-12-19 Poul Bachmann Middel, baseret paa pektinholdigt materiale, til behandling og forebyggelse af diarre hos mennesker og dyr
GB8806224D0 (en) * 1988-03-16 1988-04-13 Johnson Matthey Plc Platinum chemotherapeutic product
US20050191403A1 (en) * 2002-05-23 2005-09-01 Glutagen Pty Ltd Palliative treatment for gluten intolerance
US7976872B2 (en) * 2006-07-24 2011-07-12 L. Perrigo Company Method for distributing a pharmaceutically active compound in an excipient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1530675A (en) * 1976-06-05 1978-11-01 Wyeth John & Brother Ltd Guanidine derivatives

Also Published As

Publication number Publication date
AU7020381A (en) 1981-12-03
DE3175672D1 (en) 1987-01-15
ES514336A0 (es) 1983-04-16
ES514335A0 (es) 1983-04-16
ES8305317A1 (es) 1983-04-16
IL62809A0 (en) 1981-07-31
US4443467A (en) 1984-04-17
ES502487A0 (es) 1983-02-01
AU539121B2 (en) 1984-09-13
NZ197026A (en) 1984-05-31
IT8121847A0 (it) 1981-05-20
ES8305316A1 (es) 1983-04-16
GB2080107A (en) 1982-02-03
PT73087B (en) 1985-01-08
IT1136619B (it) 1986-09-03
DK228381A (da) 1981-11-28
PH16855A (en) 1984-03-19
ES8302647A1 (es) 1983-02-01
MY8700598A (en) 1987-12-31
PH17361A (en) 1984-08-01
FI811601L (fi) 1981-11-28
ZW11381A1 (en) 1982-11-17
EP0040947B1 (en) 1986-12-03
EP0040947A1 (en) 1981-12-02
GB2080107B (en) 1986-02-26
GR74922B (es) 1984-07-12
CA1158558A (en) 1983-12-13
IL62809A (en) 1984-03-30
PT73087A (en) 1981-06-01

Similar Documents

Publication Publication Date Title
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
MX6802E (es) Procedimiento para la preparacion de derivados carboestirilicos
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
AR227906A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-2-ciclohexen-1-alquilamina
ES501535A0 (es) Procedimiento para la preparacion de derivados de alquilfos-fonito
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES501041A0 (es) Procedimiento para la preparacion de una composicion polime-ra resistente al impacto
ES501042A0 (es) Procedimiento para la preparacion de una composicion polime-ra resistente al impacto
MX6962E (es) Procedimiento para la preparacion de una composicion farmaceutica antidiarreica
ES503407A0 (es) Procedimiento para la preparacion de derivados de pirimidina
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES501736A0 (es) Procedimiento para la preparacion de derivados de 2-guanidi-notiazol
MX6900E (es) Procedimiento para la preparacion de n-(halogenometil)acilamidas
ES504778A0 (es) Procedimiento perfeccionado para la preparacion de copolime-ros
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
ES505576A0 (es) Procedimiento para la preparacion de derivados de 7-oxopros-taciclina
MX6707E (es) Procedimiento para la preparacion de n(1-alil-2-pirrolidinilmetil)-2-metoxi-4-amino-5-metil-sulfamoil-benzamida
ES502472A0 (es) Procedimiento perfeccionado para la preparacion de copoli- meros
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas
ES505095A0 (es) Procedimiento para la preparacion de nuevas pirazinas
ES499356A0 (es) Procedimiento para la preparacion de derivados de rifamicina
ES505324A0 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas